Arcutis Biotherapeutics(us:ARQT)

14.73

-8.85%

Updated on 2025-04-04

Open:15.60
Close:14.73
High:16.04
Low:14.26
Prev Close:16.16
Volume:2.14M
Turnover:31.71M
Turnover Ratio:1.80%
Shares:118.64M
MarketCap:1.75B

About

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Address:3027 Townsgate Road,Suite 300

Market Movers